BIOLYTICA CONFERENCE

With the growing demand for personalized healthcare services and original biologics are scheduled to lose their patent by 2020, this has led to a subsequent rise in demand for drug research and to develop similar biologics (biosimilars). According to a recent report by ASSOCHAM-Sathguru, “biosimilars presents a US$240-billion global opportunity to Indian biopharmaceutical industry and the domestic market is expected to grow US$40 billion by 2030”. To facilitate drug research and development of new technologies, like bioanalytical testing, have been developed that has revolutionized the healthcare and biopharmaceutical industries. As per the latest report the Global Bioanalytical Testing Services Market is anticipated to mark 12.95% CAGR across the review period 2018 to 2023 to reach a valuation of USD 1867.30 million by 2023. This has intensified the demand for research & development across the pharmaceutical industry, which has proliferated the bioanalytical testing services market.